Wells Fargo
AAPG

Wells Fargo’s Ascentage Pharma AAPG Stock Holding History

Wells Fargo’s Portfolio AAPG Stock Details AAPG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.51K Buy
+200
New +$4.26K ﹤0.01% 6287

Other funds holding AAPG

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Wells Fargo's AAPG Position: Q2 2026 in Review

Wells Fargo opened a new position in Ascentage Pharma (AAPG) in Q2 2026: 200 shares worth $3.51K. The stake represents ﹤0.01% of the portfolio and ranks #6287 among its holdings.

8 funds tracked by Wall St. Rank hold AAPG as of Q2 2026.

  • Wells Fargo held 200 shares of Ascentage Pharma worth $3.51K as of Q2 2026.
  • Ascentage Pharma was a new Wells Fargo position in Q2 2026.
  • Ascentage Pharma made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6287 holding.
  • 8 funds tracked by Wall St. Rank held Ascentage Pharma as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.